Literature DB >> 12184439

Yellow nail syndrome associated with thiol compound therapy for rheumatoid arthritis. Two case reports.

Gaëlle Lehuédé1, Eric Toussirot, Jacques Despaux, Fabrice Michel, Daniel Wendling.   

Abstract

Yellow nail syndrome is characterized by ungual dystrophy, lower limb lymphedema, and pleural effusions or bronchiectasis. Rheumatoid arthritis is the autoimmune disorder most often associated with yellow nail syndrome. We report two new cases of yellow nail syndrome in patents receiving thiol compound therapy for rheumatoid arthritis. Eight similar cases have been reported since 1979, suggesting a possible causative effect of this class of drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12184439     DOI: 10.1016/s1297-319x(02)00421-9

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  4 in total

1.  Yellow nail syndrome in rheumatoid arthritis: a drug-induced disease?

Authors:  Eve David-Vaudey; Benedicte Jamard; Chistophe Hermant; Alain Cantagrel
Journal:  Clin Rheumatol       Date:  2004-05-04       Impact factor: 2.980

Review 2.  Bucillamine-induced yellow nail in Japanese patients with rheumatoid arthritis: two case reports and a review of 36 reported cases.

Authors:  Daiki Nakagomi; Kei Ikeda; Kawashima Hirotoshi; Hironori Kawashima; Yoshihisa Kobayashi; Akira Suto; Hiroshi Nakajima
Journal:  Rheumatol Int       Date:  2011-11-17       Impact factor: 2.631

3.  Yellow nail syndrome in rheumatoid arthritis: an aetiology beyond thiol drugs.

Authors:  Ajay Kumar Mishra; Anu Anna George; Leni George
Journal:  Oxf Med Case Reports       Date:  2016-03-16

4.  Yellow Nail Syndrome: Report of a Case Successfully Treated with Octreotide.

Authors:  Legha Lotfollahi; Atefeh Abedini; Ilad Alavi Darazam; Arda Kiani; Abbas Fadaii
Journal:  Tanaffos       Date:  2015
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.